ArticleInternational journal of methods in psychiatric research2010
Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey.
Article in International journal of methods in psychiatric research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- 12-month follow-up of an exploratory 'brief intervention' for high-frequency cannabis users among Canadian university students.Substance abuse treatment, prevention, and policy · 2012Trial
- Examining predictors of substance use and treatment adequacy among formerly incarcerated individuals with a history of opioid and cocaine use: research protocol.Health & justice · 2025Article
- Symptom Clusters in Individuals Seeking Treatment for Gambling Disorder.Journal of gambling studies · 2025Article
- Cannabis use patterns and different phenotypes in relation to other drugs use: latent class analyses from the Sao Paulo Megacity Mental Health Survey.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2025Article
- Profiles of cannabis users and impact on cannabis cessation.PloS one · 2024Article
- Differentiating people who use cannabis heavily through latent class analysis.Substance abuse treatment, prevention, and policy · 2023Article
- Typology of Adolescents Exposed to Non-medical Cannabis Marketing and Associations with Consumption Patterns.Prevention science : the official journal of the Society for Prevention Research · 2022Article
- Why do Americans use marijuana?Drug and alcohol dependence · 2021Article
- Cannabis use and patterns among middle and older aged Canadians prior to legalization: a sex-specific analysis of the Canadian Tobacco, Alcohol and Drugs Survey.BMC public health · 2021Article
- Early, Chronic, and Acute Cannabis Exposure and Their Relationship With Cognitive and Behavioral Harms.Frontiers in psychiatry · 2021Article
- Subgroup trends in alcohol and cannabis co-use and related harms during the rollout of recreational cannabis legalization in Washington state.The International journal on drug policy · 2020Article
- Young Adults With Higher Motives and Expectancies of Regular Cannabis Use Show Poorer Psychosocial Functioning.Frontiers in psychiatry · 2020Article
- Has illicit drug use become normalised in groups of Swedish youth? A latent class analysis of school survey data from 2012 to 2015.Nordisk alkohol- & narkotikatidskrift : NAT · 2019Article
- Past-month cannabis use among U.S. individuals from 2002-2015: An age-period-cohort analysis.Drug and alcohol dependence · 2018Article
- Alcohol Use and Risk of Related Problems Among Cannabis Users Is Lower Among Those With Medical Cannabis Recommendations, Though Not Due To Health.Journal of studies on alcohol and drugs · 2018Article
- Latent classes of substance use in adolescent cannabis users: predictors and subsequent substance-related harm.Frontiers in psychiatry · 2014Article
- Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs.Frontiers in psychiatry · 2013Article
- Maternal predictors of comorbid trajectories of cigarette smoking and marijuana use from early adolescence to adulthood.Addictive behaviors · 2012Article
- Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations.Canadian journal of public health = Revue canadienne de sante publiqueReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cannabis is the most prevalently used illicit drug in Canada. Current policy consists primarily of universal use prohibition rather than interventions targeting specific risks and harms relevant for public health. This study aimed to identify distinct groups of cannabis users based on defined use characteristics in the Canadian population, and examine the emerging groups' associations with differential risk and harm outcomes. One thousand three hundred and three current (i.e. use in the past three months) cannabis users, based on data from the representative cross-sectional 2004 Canadian Addiction Survey (N = 13,909), were statistically assessed by a 'latent class analysis' (LCA). Emerging classes were examined for differential associations with socio-demographic, health and behavioral indicators on the basis of chi-square and analysis of variance techniques. Four distinct classes based on use patterns were identified. The class featuring earliest onset and highest frequency of use [22% of cannabis user sample or 2.2% (95% confidence interval (CI) = 1.8-2.7%) of the Canadian adult population] was disproportionately linked to key harms, including other illicit drug use, health problems, cannabis use and driving, and cannabis use problems. A public health framework for cannabis use is needed in Canada, meaningfully targeting effective interventions towards the minority of users experiencing elevated levels of risks and harms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.